Home
Listings
TBL
IGC Pharma
Welcome
News and Filings
Press Releases
SEC Filings
XBRL Files
Home
Listings
TBL
IGC Pharma
Welcome
News and Filings
Press Releases
SEC Filings
XBRL Files
Featured
Feb 22, 2019
IGC Announces Successful Appeal of Delisting Proceedings and Imminent Relisting on NYSE American
Feb 22, 2019
Feb 22, 2019
Feb 20, 2019
IGC Announces Extension of Expiration Date and Reduction of Exercise Price of its Publicly Traded Warrants
Feb 20, 2019
Feb 20, 2019
Feb 12, 2019
IGC Announces Financial Results for Quarter Ended December 31, 2018
Feb 12, 2019
Feb 12, 2019
Oct 29, 2018
IGC to Re-list Securities on Alternative Exchange
Oct 29, 2018
Oct 29, 2018
Oct 29, 2018
NYSE American to Suspend Trading in India Globalization Capital and Commence Delisting Proceedings
Oct 29, 2018
Oct 29, 2018
Oct 16, 2018
IGC Announces Financial Results for Quarter Ended September 30, 2018
Oct 16, 2018
Oct 16, 2018
Oct 9, 2018
IGC Files Provisional Patent to Protect IP for CBD-Infused Energy Drink
Oct 9, 2018
Oct 9, 2018
Sep 26, 2018
IGC to Enter the Hemp/CBD-Infused Energy Drink Space
Sep 26, 2018
Sep 26, 2018
Sep 12, 2018
India Globalization Capital Raises $1 Million in Direct Equity Investment to Support Hyalolex Commercialization
Sep 12, 2018
Sep 12, 2018
Aug 14, 2018
IGC to Enter California Market with Hyalolex
Aug 14, 2018
Aug 14, 2018
Aug 6, 2018
IGC Announces Results of its 2018 Annual Stockholders Meeting
Aug 6, 2018
Aug 6, 2018
Aug 3, 2018
IGC Announces Financial Results for Quarter Ended June 30, 2018
Aug 3, 2018
Aug 3, 2018
Jul 25, 2018
IGC Announces “Drops of Clarity” Marketing Initiatives for Hyalolex™
Jul 25, 2018
Jul 25, 2018
Jul 10, 2018
IGC to Hold Annual Meeting of Stockholders on August 6, 2018
Jul 10, 2018
Jul 10, 2018
Jun 21, 2018
IGC Announces Financial Results for Fiscal Year Ended March 31, 2018
Jun 21, 2018
Jun 21, 2018
Apr 10, 2018
IGC Files Patent for Hyalolex Formulation
Apr 10, 2018
Apr 10, 2018
Apr 10, 2018
IGC Radica Patente para la Fórmula Hyalolex
Apr 10, 2018
Apr 10, 2018
Mar 26, 2018
IGC Partners to Launch Hyalolex in Puerto Rico
Mar 26, 2018
Mar 26, 2018
Mar 12, 2018
IGC Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)
Mar 12, 2018
Mar 12, 2018
Mar 1, 2018
IGC Partners with Parkinson’s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)
Mar 1, 2018
Mar 1, 2018
Feb 20, 2018
IGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization Stage
Feb 20, 2018
Feb 20, 2018
Feb 12, 2018
IGC's CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13
Feb 12, 2018
Feb 12, 2018
Jan 2, 2018
IGC Reports Promising Spatial Memory Results in Alzheimer’s Study
Jan 2, 2018
Jan 2, 2018
Dec 26, 2017
IGC to Use Blockchain to Address Issues Specific to the Medical Cannabis Industry
Dec 26, 2017
Dec 26, 2017
Dec 18, 2017
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 29, 2017
Dec 18, 2017
Dec 18, 2017
Dec 13, 2017
IGC Provides Update on Hyalolex for Alzheimer’s Commercialization Strategy
Dec 13, 2017
Dec 13, 2017
Dec 8, 2017
IGC Launches New Corporate Websites Highlighting Canna-Pharmaceutical Compound Portfolio
Dec 8, 2017
Dec 8, 2017
Nov 20, 2017
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 15, 2017
Nov 20, 2017
Nov 20, 2017
Nov 19, 2017
IGC Reports Second Quarter 2018 Financial Results and Operational Highlights
Nov 19, 2017
Nov 19, 2017
Nov 13, 2017
IGC Announces Results of Annual Shareholders Meeting
Nov 13, 2017
Nov 13, 2017